glp-1 news today 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 Americans turn to risky unregulated
Description
95% CI: -14.6, -2.6
GLP-1R agonist 2 (compound 2) is an effective GLP-1R agonist that exerts its activating effect by forming hydrogen bonds with the Tyr42, Cys71, and Ser84 residues of GLP-1R
The GLP-1 receptor agonist market is projected to grow from $63.24 billion in 2026 to $161.40 billion by 2034, at a CAGR of 12.43% during the forecast period 20262034.
The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.
See what the science says before you buy.
